北京大学学报(医学版) ›› 2017, Vol. 49 ›› Issue (6): 1050-1054. doi: 10.3969/j.issn.1671-167X.2017.06.020

• 论著 • 上一篇    下一篇

cN0上颌恶性肿瘤颈淋巴结转移的临床分析

孙乾1,章文博1,高敏1,于森2,毛驰1,郭传瑸1,俞光岩1,彭歆1△   

  1. (1. 北京大学口腔医学院·口腔医院,口腔颌面外科口腔数字化医疗技术和材料国家工程实验室口腔数字医学北京市重点实验室, 北京100081;2. 北京大学口腔医学院·口腔医院,第二门诊部口腔颌面外科口腔数字化医疗技术和材料国家工程实验室口腔数字医学北京市重点实验室, 北京100101)
  • 出版日期:2017-12-18 发布日期:2017-12-18
  • 通讯作者: 彭歆 E-mail: pxpengxin@263.net
  • 基金资助:
    国家科技支撑计划项目(2014BAI04B06)资助

Clinical analysis of cervical lymph node metastasis of cN0 maxillary malignant tumor

SUN Qian1, ZHANG Wen-bo1, GAO Min1, YU Sen2, MAO Chi1, GUO Chuan-bin1, YU Guang-yan1, PENG Xin1△   

  1. (1. Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China; 2. Department of Oral and Maxillofacial Surgery, Second Clinical Division, Peking University School and Hospital of Stomatology & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100101, China)
  • Online:2017-12-18 Published:2017-12-18
  • Contact: PENG Xin E-mail: pxpengxin@263.net
  • Supported by:
    Supported by the National Science & Technology Pillar Program (2014BAI04B06)

摘要: 目的:探讨和比较不同病理类型临床颈淋巴结阴性(clinically negative neck lymph node,cN0)上颌恶性肿瘤的颈淋巴结转移率,为此类患者颈部淋巴结的处理提供参考。方法: 选择1990年至2010年就诊于北京大学口腔医院具有完整临床及随访资料的cN0上颌恶性肿瘤患者277例,记录颈淋巴结转移情况及相关临床信息,研究不同病理类型上颌恶性肿瘤颈淋巴结转移的发生规律,并通过SPSS 19.0统计学软件分析影响上颈恶性肿瘤淋巴结转移的相关因素。结果: 277例cN0上颌恶性肿瘤患者的总体颈淋巴结转移发生率为15.5%(43/277),上颌鳞状细胞癌因其较强的淋巴结转移倾向,颈淋巴结转移率为33.0%;腺源性癌的整体转移率较低,为7.6%,且发生颈淋巴结转移的时间较晚,但高度恶性腺源性癌的淋巴结转移率明显高于中、低度恶性腺源性癌(分别为P=0.037), 其中非特异性腺癌、低分化黏液表皮样癌、导管癌的颈淋巴结转移率高于15%,而同属于高度恶性肿瘤的腺样囊性癌与肌上皮癌的转移率较低;肉瘤类恶性肿瘤的整体淋巴结转移率很低,仅为4.9%。结论: 建议对cN0上颌鳞状细胞癌患者行选择性颈淋巴结清扫术,对于非特异性腺癌、低分化黏液表皮样癌、导管癌等高度恶性腺源性癌患者可行选择性颈淋巴结清扫术,对于肉瘤类患者可对颈部进行密切观察。

关键词: 淋巴结, 上颌骨肿瘤, 淋巴转移,

Abstract: Objective: To investigate the cervical lymphatic metastasis rates of clinically negative neck lymph node (cN0) maxillary malignant tumors, to compare the cervical lymphatic metastasis rates of the various pathological types, and to provide the reference for the treatment of the neck of the patients with cN0 maxillary malignant tumor. Methods: The clinical data of 277 cases with cN0 maxillary malignant tumor, treated in the department of oral and maxillofacial surgery of Peking University School and Hospital of Stomatology from 1990 to 2010, were reviewed. The cervical lymph node metastasis and the related clinical information were recorded. The clinical information including histopathology type of the tumors, tumor grade, primary site and TNM staging, as well as other demographic and clinical data, were retrieved from the electronic medical record system (EMRS) of the hospital. The pathogenesis of cervical lymph node metastasis in maxillary malignant tumors of different histopathological types, and the factors related to lymph node metastasis of upper cervical malignancy were analyzed by SPSS 19.0 statistical software. Results: The overall cervical lymph node metastasis rate of the 277 patients with cN0 maxillary malignant tumor was 15.5% (43/277). Maxillary squamous cell carcinoma (SCC) had a strong cervical lymph node metastasis tendency and the rate was 33.0%. The overall metastatic rate of adenocarcinoma was 7.6% lower than that of SCC, and the occurrence of cervical lymph node metastasis time was relatively late, but the metastasis rate of highly malignant grade salivary gland carcinoma was significantly higher than that of intermediate and low grade carcinoma (P=0.037). The metastatic rates of some highly malignant cN0 salivary gland carcinomas including adenocarcinoma, not other specified, high-grade mucoepidermoid carcinoma (MEC), and salivary duct carcinoma were exceeded 15%, while the metastasis rates of adenoid cystic carcinoma and myoepithelial carcinoma were lower. The metastasis rate of the sarcomas was very low with the rate of 4.9%. Conclusion: Selective neck dissection (SND) is recommended for cN0 maxillary SCC and feasible for some highly malignant cN0 salivary gland carcinomas including adenocarcinoma, not other specified, highgrade MEC, salivary duct carcinoma. The neck can be closely observed for the patients with maxillary sarcoma.

Key words: Lymph nodes, Maxillary neoplasms, Lymphatic metastasis, Neck

中图分类号: 

  • R739.8
[1] 步召德, 冯梦宇, 季科. 早期胃癌行前哨淋巴结导航手术的实践与思考[J]. 北京大学学报(医学版), 2026, 58(2): 239-243.
[2] 宋畅, 冯琦琛, 杨广鑫, 刘启佳, 王昌明, 李选. 液-固兼用曲张静脉栓塞技术联合专用支架在经颈内静脉肝内门体分流术中的应用[J]. 北京大学学报(医学版), 2025, 57(5): 1010-1013.
[3] 王泽远, 于栓宝, 郑浩轲, 陶金, 范雅峰, 张雪培. 基于临床特征和多参数MRI的前列腺癌盆腔淋巴结转移的术前预测模型[J]. 北京大学学报(医学版), 2025, 57(4): 684-691.
[4] 宁太国, 潘利平, 叶一林, 曹永平. 股骨粗隆间骨折术后同侧股骨颈骨折1例[J]. 北京大学学报(医学版), 2025, 57(3): 610-613.
[5] 李伟浩, 李晶, 张学民, 李伟, 李清乐, 张小明. 术中回收式自体输血对颈动脉体瘤切除术后肿瘤预后的影响[J]. 北京大学学报(医学版), 2025, 57(2): 272-276.
[6] 田杨, 韩永正, 李娇, 王明亚, 曲音音, 房景超, 金辉, 李民, 王军, 徐懋, 王圣林, 郭向阳. 颈椎前路手术后硬膜外血肿的发生率和危险因素[J]. 北京大学学报(医学版), 2024, 56(6): 1058-1064.
[7] 田素青, 孙海涛, 赵田地, 王巍. 6D治疗床辅助影像引导下放射治疗头颈部肿瘤摆位误差分析[J]. 北京大学学报(医学版), 2024, 56(6): 1097-1100.
[8] 罗丹, 黄海建, 陈新, 陈小岩. 原发子宫肝样腺癌2例临床病理分析及文献复习[J]. 北京大学学报(医学版), 2024, 56(6): 1126-1131.
[9] 汪琪伟, 包鹏宇, 洪士皓, 杨昕, 王宇, 曹永平. 改良股骨颈截骨术在伴严重屈曲畸形强直性脊柱炎患者手术治疗过程中的疗效[J]. 北京大学学报(医学版), 2024, 56(5): 884-889.
[10] 刘东武, 陈杰, 高明利, 于静. 类风湿关节炎伴发淋巴结Castleman样病理改变1例[J]. 北京大学学报(医学版), 2024, 56(5): 928-931.
[11] 费秀文,刘斯,汪波,董爱梅. 成人及儿童组织坏死性淋巴结炎临床特征及治疗[J]. 北京大学学报(医学版), 2024, 56(3): 533-540.
[12] 唐祖南,胡耒豪,陈震,于尧,章文博,彭歆. 增强现实技术在口腔颌面颈部解剖识别中的应用评价[J]. 北京大学学报(医学版), 2024, 56(3): 541-545.
[13] 林国中,马长城,吴超,司雨,杨军. 微通道技术在颈椎管肿瘤微创切除术中的应用[J]. 北京大学学报(医学版), 2024, 56(2): 318-321.
[14] 彭圣嘉,祁雨,孙丽杰,李丹,王新宇,韩江莉,陈宝霞,张媛. 传入压力反射衰竭合并低钠血症1例[J]. 北京大学学报(医学版), 2024, 56(2): 357-361.
[15] 胡攀攀,李彦,刘啸,唐彦超,李梓赫,刘忠军. 自稳式人工椎体在颈椎前路手术中的应用[J]. 北京大学学报(医学版), 2024, 56(1): 161-166.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!